UKIPO trademark

AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE

RegisteredUKIPOFigurative markClass 5

"AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE" is a figurative mark owned by Seqirus Inc., filed at the UKIPO on September 17, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Seqirus Inc. portfolioGet this data via the API
Official UKIPO record
AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE trademark as filed
As filed with the UKIPO
Status
Registered
Since September 17, 2025
Filed
September 17, 2025
Registered
December 5, 2025
Expires
September 17, 2035
Application no.
UK00004265241
Registration no.
UK00004265241
Office
UKIPO
Intellectual Property Office
Mark type
Figurative mark
1 class
Ownership

Who owns AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Seqirus Inc.

United States

268 trademarks in the portfolioView company

Representative

Baker & McKenzie LLP

Baker & McKenzie LLP

Goods and services

What the mark covers

The products and services AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE is filed for, grouped by Nice class.

FAQ

About AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE

Who owns the trademark "AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE"?

The UKIPO trademark "AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE" (application UK00004265241) is owned by Seqirus Inc.

What is the status of "AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE"?

Its status at the UKIPO is: registered.

When was "AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE" registered?

It was registered on December 5, 2025 and is due to expire on September 17, 2035.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019f4268-5139-756a-81d5-6179fa454d64
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019f4268-5139-756a-81d5-6179fa454d64",
  "object": "trademark",
  "mark_text": "AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "GB",
  "application_number": "UK00004265241",
  "filing_date": "2025-09-17",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Seqirus Inc.",
      "entity_id": "ent_019eb7d7-073e-746b-967e-2a965cfa764c"
    }
  ]
}